RecruitingNCT06869694

Energy CT in Imaging and Diagnosis of Gastric Cancer

Diagnostic and Predictive Performance of Dual-/ Muti- Energy CT and MRI in the Treatment Response and Survival Prognosis of Gastric Cancer


Sponsor

The First Affiliated Hospital of Zhengzhou University

Enrollment

300 participants

Start Date

Sep 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Accurate preoperative prediction of risk stratification, treatment response, and survival prognosis in gastric cancer is important for improving clinical treatment decisions, prolonging patient survival, and improving patient quality of life. The purpose of this study is to investigate the performance of the multi-parametric magnetic resonance imaging (mpMRI) and Dual-/Muti-energy CT and photon-counting Detector CT(PCD-CT) in the diagnosis and management of gastric cancer.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Pathological biopsy confirmed gastric cancer;
  • Surgery: patients undergoing radical gastrectomy. Patients undergoing exploratory abdominal surgery or palliative tumor resection were still included in the study when peritoneal metastasis or adjacent organ invasion was identified intraoperatively and radical surgical resection was not possible.

Exclusion Criteria3

  • Refusal or inability to sign informed consent;
  • CT or MRI images are poor or the focus is small and CT images are not clear;
  • Patients with other tumors complicated with patients with important organ dysfunction.

Interventions

DEVICEcomputerized tomography

mpMRI and Photon-counting Detector CT scan


Locations(1)

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, China, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06869694


Related Trials